Live feed17:47:32·1502dINSIDERFilingvia QuantisnowSEC Form 4: Valliant John sold $27,126 worth of shares (3,604 units at $7.53) as part of a pre-agreed trading plan, decreasing direct ownership by 0.93% to 382,360 unitsByQuantisnow·Wall Street's wire, on your screen.FUSN· Fusion Pharmaceuticals Inc.Health CareOriginal source